H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)

H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $14.00 price target on Brainsway (NASDAQ: BWAY).

The analyst commented: "Guidance for 2026 adjusted EBITDA doubled. On July 15, 2026, Gevo raised its guidance for expected 2026 adjusted EBITDA to $60M, compared to approximately $30M previously. A significant driver for this revision was the completion of its Canada Clean Fuel Regulation (CFR) carbon intensity (CI) pathway for low-carbon ethanol with carbon capture and sequestration (CCS). We believe these credits are worth upward of $300/ton of CO2; the company indicated that it has begun selling these CFR credits and revenues are slated to be recognized in 2H26. Part of the upward revision was also driven by a modest increase in the company’s targeted monetization of its Section 45Z tax credits during 2026, to $70M from approximately $64M previously. Reiterate Buy and $14 price target."

For an analyst ratings summary and ratings history on Brainsway click here. For more ratings news on Brainsway click here.

Shares of Brainsway closed at $14.84 yesterday.

You May Also Be Interested In

• H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
• Abbott Labs (ABT) Reiterated at Buy by Benchmark After Q2 Revenue Beat
• First Financial Bankshares (FFIN) Reiterated at Buy by Benchmark After Solid Earnings